Biocompatible Drug Delivery System Based on a MOF Platform for a Sustained and Controlled Release of the Poorly Soluble Drug Norfloxacin

[Image: see text] Norfloxacin (NFX), an important antibacterial fluoroquinolone, is a class IV drug according to the biopharmaceutics classification system (BCS) and has low solubility and permeability issues. Such poor physicochemical properties of drug molecules lead to poor delivery and are of se...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Preety, Kumari, Sarita, Yadav, Anand, Bhardwaj, Priya, Maruthi, Mulaka, Chakraborty, Anindita, Kanoo, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413448/
https://www.ncbi.nlm.nih.gov/pubmed/37576664
http://dx.doi.org/10.1021/acsomega.3c02418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413448/
https://www.ncbi.nlm.nih.gov/pubmed/37576664
http://dx.doi.org/10.1021/acsomega.3c02418

Ejemplares similares